ERBB4 receptor linked to early Alzheimer’s changes, offering a new therapeutic target

1 min read
Source: The Independent
ERBB4 receptor linked to early Alzheimer’s changes, offering a new therapeutic target
Photo: The Independent
TL;DR

A South Korean study suggests the ERBB4 receptor becomes abnormally active in excitatory neurons during Alzheimer's, triggering multiple disease processes. In mouse models, removing ERBB4 from these neurons reduced harmful brain activity, lessened glial reactivity and plaques, and improved memory, pointing to ERBB4 as an early driver of Alzheimer's pathology and a potential therapeutic target.

Share this article

Want the full story? Read the original reporting

Read on The Independent